BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours

BACKGROUND: Traditional radiotherapy and chemotherapy have been intensively studied for their role in the treatment of tumours. However, these therapies often cause side effects for patients, which calls for the development of novel treatment options for tumours. B-cell lymphoma-2 (Bcl-2)/adenovirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qin, Fu, Wenhao, Fu, Yutang, Ye, Wenjing, Yan, Huiqiong, Yu, Zecheng, Li, Ruirui, Cai, Yili, Chen, Yuxin, Wang, Lingyun, Wei, Xianqiao, Chen, Yangkun, Zhang, Yuheng, Ying, Huazhong, Tang, Furong, Dai, Fangwei, Han, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466744/
https://www.ncbi.nlm.nih.gov/pubmed/37649051
http://dx.doi.org/10.1186/s12943-023-01808-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466744/
https://www.ncbi.nlm.nih.gov/pubmed/37649051
http://dx.doi.org/10.1186/s12943-023-01808-9

Ejemplares similares